Position in BLLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,353,434
+$6,857,261 QoQ
Shares Held
86,293
+94.8% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#34
of 156 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026LORD, ABBETT & CO. LLC holds $667,699,391 across 9 Diagnostics & Research names. BLLN ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
1,813,491 | $272,078,054 | |
| 2 | LH |
Labcorp Holdings Inc.
|
530,729 | $148,604,120 | |
| 3 | NTRA |
Natera, Inc.
|
466,773 | $126,705,530 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
370,315 | $71,552,264 | |
| 5 | DHR |
Danaher Corp /De/
|
158,734 | $30,235,652 | |
| 6 | BLLN |
BillionToOne, Inc.
This page
|
86,293 | $10,353,434 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
8,363 | $4,402,617 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
|
7,515 | $3,767,720 |
All Filings in BLLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,353,434 | 86,293 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,496,173 | 44,289 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,789,846 | 46,308 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||